Skip to main content

Table 3 Comparison of cardiovascular risk markers and clinical characteristics based on duration on antiretroviral therapy (ART) in HIV-infected study participants using one-way ANOVA

From: Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study

Parameter

≤5 years (n = 49)

6–9 years (n = 50)

≥10 years (n = 51)

p-value

≤5yrsVS 6-9 yrs. p-value

≤5yrsVS ≥10 yrs. p-value

6-9yrsVS ≥10 yrs. p-value

Age (yrs)

41.35 ± 9.43

42.60 ± 8.61

47.14 ± 7.13

0.002*

0.740

0.002*

0.021*

ABI

0.93 ± 0.07

0.94 ± 0.07

0.89 ± 0.09

0.012*

0.715

0.039*

0.011*

BMI (Kg/m2)

25.46 ± 5.76

25.37 ± 5.61

25.45 ± 5.12

0.996

0.996

1.000

0.997

WC (cm)

88.98 ± 11.67

90.82 ± 11.76

90.55 ± 11.29

0.695

0.709

0.777

0.992

WHR

0.87 ± 0.06

0.88 ± 0.05

0.87 ± 0.037

0.505

0.488

0.929

0.711

SBP (mmHg)

120 ± 21

118 ± 18

127 ± 22

0.054

0.833

0.189

0.053

DBP (mmHg)

82 ± 8

80 ± 7.27

82 ± 8

0.128

0.176

0.189

0.191

Nadir CD4+ T

cell (cells/mm3)

210 ± 224

272 ± 210

304 ± 247

0.122

0.382

0.106

0.754

Current CD4+ T

cell (cells/mm3)

352 ± 220

560 ± 265

596 ± 247

0.001*

0.001*

0.001*

0.745

FPG (mmol/L)

4.40 ± 0.52

4.61 ± 1.16

4.53 ± 0.54

0.413

0.383

0.709

0.850

TC (mmol/L)

4.43 ± 1.12

4.84 ± 1.02

4.57 ± 0.74

0.112

0.101

0.774

0.343

TG (mmol/L)

2.17 ± 0.15

2.22 ± 0.14

2.19 ± 0.14

0.141

0.127

0.397

0.387

HDL-C (mmol/L)

1.19 ± 0.07

1.20 ± 0.06

1.19 ± 0.06

0.582

0.884

0.841

0.552

LDL-C (mmol/L)

2.25 ± 1.07

2.62 ± 0.99

2.38 ± 0.72

0.141

0.125

0.764

0.409

  1. Data are presented as mean ± standard deviation. * = significant at P < 0.05. PAD Peripheral artery disease, ABI Ankle brachial index, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, WHR Waist to hip ratio, CVD Cardiovascular disease, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, FPG Fasting plasma glucose